Wednesday, August 27, 2014
Inquirer Daily News

No label needed for genetically engineered salmon?

The FDA is holding a hearing tomorrow, and has not yet approved sale of AquAdvantage Salmon, a genetically engineered fish produced by AquaBounty Technologies Inc. But a report this weekend said its approval would mean no label is necessary.

No label needed for genetically engineered salmon?

The FDA is holding a hearing tomorrow on AquAdvantage Salmon, a genetically engineered fish produced by AquaBounty Technologies Inc., and the agency's public statements suggest that if it's approved for sale, the altered salmon may have to be labeled in a way that distinguishes it from its non-genetically engineered counterparts. The prehearing document says: "If it is approved, food made from AquAdvantage Salmon must, like all foods, bear an appropriate name and a label that is truthful and not misleading. This public hearing will assist FDA in the application of its relevant food labeling legal principles as they relate to AquAdvantage Salmon."

But a Washington Post report this weekend said that AquaAdvantage's approval would make that question largely moot. If the FDA says it's good enough to eat, in essence, that would mean no clear labeling would be necessary:

As the Food and Drug Administration considers whether to approve genetically modified salmon, one thing seems certain: Shoppers staring at fillets in the seafood department will find it tough to pick out the conventional fish from the one created with genes from another species.

Despite a growing public demand for more information about how food is produced, that won't happen with the salmon because of idiosyncracies embedded in federal regulations.

The FDA says it cannot require a label on the genetically modified food once it determines that the altered fish is not "materially" different from other salmon - something agency scientists have said is true.

Perhaps more surprising, conventional food makers say the FDA has made it difficult for them to boast that their products do not contain genetically modified ingredients.

The labeling question has emerged as the FDA determines whether to approve the fish, an Atlantic salmon known as AquAdvantage that grows twice as fast as its natural counterpart. The decision carries great weight because, while genetically modified agriculture has been permitted for years and engineered crops are widely used in processed foods, this would be the first modified animal allowed for human consumption in the United States.The AquAdvantage salmon has been given a gene from the ocean pout, an eel-like fish, and a growth hormone from a Chinook salmon.

'The public wants to know'

Consumer advocates say they worry about labeling for genetically engineered beef, pork and other fish, which are lining up behind the salmon for federal approval.

"The public wants to know and the public has a right to know," said Marion Nestle, a professor in the Nutrition, Food Studies and Public Health Department at New York University. "I think the agency has discretion, but it's under enormous political pressure to approve [the salmon] without labeling."

The debate will be taken up this week, with an advisory committee meeting Sunday and Monday on whether to allow the modified fish, and a separate panel meeting Tuesday on whether the fish should be labeled. The panels will offer recommendations to the FDA commissioner, who will decide both matters.

The biotechnology industry is opposed to mandatory labeling, saying it will only bewilder a public that is not well informed about genetic engineering.

"Extra labeling only confuses the consumer," said David Edwards, director of animal biotechnology at the Biotechnology Industry Organization. "It differentiates products that are not different. As we stick more labels on products that don't really tell us anything more, it makes it harder for consumers to make their choices."

Click here to see the rest of the story by reporter Lyndsey Layton.

Read about European Union concerns over transgenic fish.

Jeff Gelles Inquirer Business Columnist
About this blog

Jeff Gelles, who writes the Inquirer's weekly Consumer 14.0 and Tech Life columns, takes a broad look at the marketplace of goods, services, and ideas.

Reach Jeff at jgelles@phillynews.com.

Jeff Gelles Inquirer Business Columnist
Business Videos:
Also on Philly.com:
Stay Connected